Structure of PDB 3vjl Chain B |
>3vjlB (length=729) Species: 9606 (Homo sapiens) [Search protein sequence] |
DSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSS VFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDL NKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITW TGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIE YSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQI TAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRW NCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYF QIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLS DYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVN DKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKS KKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQG DKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTS MVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNST VMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTD EDHGIASSTAHQHIYTHMSHFIKQCFSLP |
|
PDB | 3vjl Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes |
Chain | B |
Resolution | 2.393 Å |
3D structure |
|
|
|
|
|
|